Amelioration of protein misfolding disease by rapamycin: translation or autophagy?

Autophagy
Andreas WyttenbachAviva M Tolkovsky

Abstract

Rapamycin is an inhibitor of mTOR, a key component of the mTORC1 complex that controls the growth and survival of cells in response to growth factors, nutrients, energy balance and stresses. The downstream targets of mTORC1 include ribosome biogenesis, transcription, translation and macroautophagy. Recently it was proposed that rapamycin and its derivatives enhance the clearance (and/or reduce the accumulation) of mutant intracellular proteins causing proteinopathies such as tau, alpha-synuclein, ataxin-3, and full-length or fragments of huntingtin containing a polyglutamine (polyQ) expansion, by upregulating macroautophagy. We tested this proposal directly using macroautophagy-deficient fibroblasts. We found that rapamycin inhibits the aggregation of a fragment of huntingtin (exon 1) containing 97 polyQs similarly in macroautophagy-proficient (Atg5(+/+)) and macroautophagy-deficient (Atg5(-/-)) cells. These data demonstrate that autophagy is not the only mechanism by which rapamycin can alleviate the accumulation of misfolded proteins. Our data suggest that rapamycin inhibits mutant huntingtin fragment accumulation due to inhibition of protein synthesis. A model illustrates how a modest reduction in polyQ synthesis can lead to...Continue Reading

Citations

Aug 18, 2009·Nature Neuroscience·Luke S TainAlexander J Whitworth
Sep 20, 2011·Experimental Cell Research·Alise HyrskyluotoLaura Korhonen
Apr 24, 2010·Neuromuscular Disorders : NMD·Olivier Benveniste, David Hilton-Jones
Nov 4, 2008·Protein Expression and Purification·Alexandre PozzaAttilio Di Pietro
May 15, 2013·PloS One·Sefika OzcelikDavid Theo Winkler
Nov 22, 2019·Reviews in the Neurosciences·Bor Luen Tang
Sep 14, 2010·Proceedings of the National Academy of Sciences of the United States of America·Andrey S TsvetkovSteven Finkbeiner
Oct 11, 2017·Annual Review of Cell and Developmental Biology·Esther PillaAnne Bertolotti
Apr 15, 2020·Antimicrobial Agents and Chemotherapy·Arnau BioscaXavier Fernàndez-Busquets
Jun 27, 2021·Progress in Neurobiology·Maoxin Huang, Shengdi Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Autophagy & Aging: Inhibitors

The feed focuses on the role of nuclear export inhibitors and their effect on autophagy and the aging process.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.